Dr. Alexander Deiters' lab at the University of Pittsburgh focuses on enhancing cancer therapy through innovative technologies. The research centers on developing small molecule adaptors that improve the efficacy of Chimeric Antigen Receptor (CAR) T cell therapies, by enabling them to target multiple types of cancer cells more precisely and effectively. This work seeks to make cancer treatments more accessible and improve patient outcomes for a variety of diseases.